Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Control of viral hepatitis infection in Africa: Are we dreaming?
Vaccine, Volume 31, No. 2, Year 2013
Notification
URL copied to clipboard!
Description
Background: At least five different types of viral hepatitis cause problems of significant public health importance in Africa, where together they constitute a huge burden of disease. But until now, efforts to control the infections have been largely piecemeal. Analysis of the strategies needed to control each virus, however, reveals major overlaps. Proposal: We propose that the control of these infections in the WHO African Region should start with the common strategies rather than with each disease. But this approach presents potentially huge problems to overcome, such as the difficulty of integrating multiple health service elements - the track record for successful integration of such services is not good. This is despite encouraging rhetoric from donors and national leaders alike. And to succeed, disparate programmes must work closely together. But we believe that the time is right to create new opportunities for prevention and treatment of hepatitis, including increasing education, and promoting screening and treatment for more than 500 million people already infected with hepatitis B and C viruses. Impact: The impact of these efforts on decreasing mortality and morbidity will be significant because of the high burden of disease from these infections, and also because the effect will spill over to benefit the control of other communicable diseases and health systems strengthening. Such a project will inevitably involve multiple strategies that will vary somewhat according to the epidemiology of the diseases and the location. © 2012 Elsevier Ltd.
Authors & Co-Authors
Mihigo, Richard M.
Unknown Affiliation
Nshimirimana, Deo
Unknown Affiliation
Hall, Andrew J.
Unknown Affiliation
Kew, Michael Charles
Unknown Affiliation
Wiersma, Steven Todd
Unknown Affiliation
Clements, C. John
Unknown Affiliation
Statistics
Citations: 8
Authors: 6
Affiliations: 5
Identifiers
Doi:
10.1016/j.vaccine.2012.11.001
ISSN:
0264410X
e-ISSN:
18732518
Research Areas
Infectious Diseases